2021
DOI: 10.12688/hrbopenres.13208.1
|View full text |Cite
|
Sign up to set email alerts
|

Current management of adults receiving oral anti-cancer medications: A scoping review protocol

Abstract: Oncology has been undergoing a profound transition in the last ten years or more with the increase in oral anti-cancer medications. Approximately 25% of all anti-cancer medication is now designed for oral use and this is likely to increase prospectively. These treatments are convenient for patients and are often preferred by them, yet there are similar safely and toxicity concerns as there are to intravenous treatment. Oral anti-cancer medications (OAMs) have the potential to alleviate capacity issues in cance… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 22 publications
(14 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?